Latest filing published 03 Aug 2026 for Vaxcyte, Inc., €468k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Guggenhime Andrew: trading record in brief
All filings by Guggenhime Andrew on record concern Vaxcyte, Inc. In total, 3 filings cover trades dated from 18 June 2026 to 3 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 3 August 2026 came the latest disclosure, a transaction for €468k in Vaxcyte, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Guggenhime Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$53.99CommonSEC144:0001969223-26-000830
- 10,000 shares@ US$57.760.0067% mcap14.2% of flowCommonSEC144:0001969223-26-000761
- 10,000 shares@ US$53.000.0063% mcap11.0% of flowCommonSEC144:0001969223-26-000716
3 of 3 declarations
